Tag: FDA inspections
Quality concerns: when clinicians question generic manufacturing
Clinicians are raising alarms about generic drug quality, especially when manufactured overseas. Studies show higher adverse event rates for generics made in India compared to U.S.-made versions. Transparency, inspection reform, and domestic production may be key to fixing the system.